Try to get into Centocor Ortho Biotech or Tibotec. The biotech divisions of J&J are considered the cream of the crop of all J&J companies so the salaries and bonuses of the reps are extraordinarily high, the highest in all biotech companies out there plus the amazing benefits like pension, stock, great company car, etc that J&J tops all the other companies with. Despite the high salaries, the work expectations are extremely low. Specialists and Hospitals have closed their doors to drug reps so they don't even see their physician targets anymore yet work with their managers to fake their calls, pad their numbers, and manipulate the data so it looks like they are being effective in the field. It's all smoke and mirrors. It's very easy to do and they're all getting away with it, have been for years. You'll spend 70% of your time at home waiting for something big to happen. The reps and managers are older and have more years in the business so the work expectations for the old fogeys such as programs, paperwork, etc are nonexistent compared to the other J&J companies. No micromanagement, very stress-free. As for the front-line -- Pathetic Pricara-less is the Raritan joke of J&J. You will not be rewarded, respected or recognized for any intelligence. It is the low game. Pricara is not better than bad. You will not be asked for your opinion because your opinion doesn't matter. Because the biotech divisions are doing so well they are getting all the credit for the success of the products even though they have absolutely nothing to do with it and reaping all the rewards. Best gig ever. Go for it.
I've read your BS on other J&J sites. OK you were fired from OBI and you are pissed so you make s@@t up. Just go away.
Hey HO poster....what is going on with pricara? The silence is deafening here. I hear only upper management shifts and then I hear about a full realignment. Any inside info?
Funny how reps and managers here can't handle the truth about themselves and what they really produce and add to jnj's revenue. Once a person sheds the truth on this site someone automaticallys says they're a pissed off rep who got fired. Truth is there's more than one person who knows the truth about what a joke this job is and the disparity between biotech and pharma pay in the industry. Everyone at the HO thinks the reps and managers in the field are a complete joke. We know the truth because many of us were once in the field but had higher aspirations than coasting the rest of our lives. Many of us are friends with reps and managers and hear what's really going on in the field.
It's getting a lot harder to figure what's going to happen next with the pharma and biotech op cos, even at the HO. We used to get a better read on when things are happening based on the amount of meetings and comments after the meetings but there's so much secrecy now that it's getting a lot harder to figure out what's gonna happen next and when. The merge between pharma and biotech is in effect and it's about time. There are so many accomplished pharma reps who deserve to be at cobi taking the lead with jnj's top products and so many lazy cows at cobi who deserve to be back in pharma or consumer products salary range based on their work efforts. By shaking things up with new managers a lot of the complacency in the field will be gone and everyone in the field will be where they deserve to be. A lot of the deadweight will be gone but jnj will be a better run company.
the best place at jnj is on the board of directors and executive level. Pay for performance is not applicable at this level. they vote for there own raises and cut heads to achieve there goals. jnj was 60 when the ceo started and its 60 now. thank god weldon still gets his raises, stock, and has not been impacted except for the large amounts of red meat impacting his colon
Cordis is hands down the best J&J company. Mediocre cardiology division but one of the best peripheral vascular in the business. No matter which pharma company you're with you need to try and break into the device side. Pharma reps are being phased out. Good luck.
I agree with you but device dms know that pharma/biotech "detail people" don't work and they know better than to hire them for a sales position. Pharma and biotech "detail people" are going to have to face the music that they never deserved or earned the high salaries they received for years for working the 11:30-1:30 lunch in-service shift and that the majority of them couldn't hack it in device sales.
Ortho Women's Health was at one time the gold standard within JNJ's pharmaceutical sector and it is now gone so never assume that your current company no matter how successful it is now will never be phased out................
Here we go again -- known information -- benefiting J&J and putting the consumer at risk Los Angeles, CA: A recent lawsuit involving Stevens Johnson Syndrome may result in a drug company changing its warning label. A California state appeals court has found that Johnson & Johnson knew about the risk of Stevens Johnson Syndrome, sometimes known as SJS, with its drug Motrin but did not warn consumers. Although the US Food and Drug Administration (FDA) does not currently require a warning about SJS, the courts might require a change to labeling separate from the FDA.
Having come from PriBARA... COBI is easy money and low pressure. You'll live longer if you leave the primary care cooker.
That's the irony of biotech versus pharma jobs. Biotech reps get more money for doing less work. The merger of the two within jnj will allow the cream to rise to the top. The pharma reps are gonna give the lazy biotech old farts a real run for their money.
Merger? Really? When? It makes sense since we all do the same thing. If changes are coming, please hurry. The status quo is in need of an overhaul. No job losses though, please no layoffs!
Unfortunately when there are mergers there are layoffs. Especially during a recession when the career of a pharma/biotech "detail person" is disappearing at such a fast rate. Just continue to work hard and you will survive any inevitable layoffs
Antidote: new cancer detection test --Marc Siegel, MD January 14 2011 Johnson & Johnson has received a lot of criticism lately because of the McNeil recalls of cold medicines, especially those for children. Factories must follow protocols which include sterility and proper oversights. At the same time, J&J is getting a badly needed pick-me-up from its Veridex division. They are bringing to market a new cancer detection test that was developed at Massachusetts General Hospital and is now being studied there and at three other major cancer centers around the country. The test utilizes a microchip that resembles a lab slide. It is covered with 78,000 tiny prongs, coated with antibodies that bind to tumor cells. The chip is slid into the bloodstream where more than a billion normal cells bounce off it for every cancer cell that sticks. Then it's examined for its genetic make-up. The amazing finding here is that cancer cells circulate in the blood even when the actual tumor is to be found in a discrete location such as the breast, colon, kidney or skin. The test has enormous potential for assessing and modifying cancer treatment, and has already been studied in this regard with trials appearing in major journals. The potential of the test may even go beyond treatment and onto early detection, since we are making cancer cells long before a tumor actually develops. It is part of the range and success of a large company like J&J that at the same time that it is receiving a repeated black eye for McNeil, and also receiving accolades for Veridex. If only the news media reported both these stories accurately and evenly. Marc Siegel, MD, is an internist and professor of medicine at New York University and the author of False Alarm: The Truth About the Epidemic of Fear
